Future oncology
-
Review Meta Analysis
Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis.
We performed a meta-analysis of the risk of endocrine adverse events associated with immune check point inhibitors. ⋯ Our meta-analysis has demonstrated that the use of immune check point inhibitors is associated with an increased risk of hypothyroidism, hyperthyroidism, hypophysitis and adrenal insufficiency compared with control.